Market closed
Benitec Biopharma Inc./$BNTC
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.
Ticker
$BNTC
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
16
Website
BNTC Metrics
BasicAdvanced
$348M
-
-$1.94
0.77
-
Price and volume
Market cap
$348M
Beta
0.77
52-week high
$16.90
52-week low
$10.50
Average daily volume
56K
Financial strength
Current ratio
25.482
Quick ratio
25.343
Total debt to equity
0.18
Management effectiveness
Return on assets (TTM)
-29.99%
Return on equity (TTM)
-46.85%
Valuation
Price to book
4.21
Price to tangible book (TTM)
4.21
Price to free cash flow (TTM)
-6.876
Growth
Earnings per share change (TTM)
-82.70%
3-year earnings per share growth (CAGR)
-64.43%
BNTC News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Benitec Biopharma Inc. stock?
Benitec Biopharma Inc. (BNTC) has a market cap of $348M as of April 30, 2025.
What is the P/E ratio for Benitec Biopharma Inc. stock?
The price to earnings (P/E) ratio for Benitec Biopharma Inc. (BNTC) stock is 0 as of April 30, 2025.
Does Benitec Biopharma Inc. stock pay dividends?
No, Benitec Biopharma Inc. (BNTC) stock does not pay dividends to its shareholders as of April 30, 2025.
When is the next Benitec Biopharma Inc. dividend payment date?
Benitec Biopharma Inc. (BNTC) stock does not pay dividends to its shareholders.
What is the beta indicator for Benitec Biopharma Inc.?
Benitec Biopharma Inc. (BNTC) has a beta rating of 0.77. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.